piramal enterprises ltd
Nandini A. Piramal
General Manager of Strategic Marketing, Executive Director and Member of Corporate Social Responsibility Committee, Piramal Enterprises Limited
|Age||Total Calculated Compensation||This person is connected to 19 board members in 2 different organizations across 1 different industries.|
See Board Relationships
As of Fiscal Year 2014
Ms. Nandini A. Piramal has been General Manager of Strategic Marketing at Piramal Healthcare Ltd. (AKA Piramal Enterprises Limited) since June 2006. Ms. Piramal served at McKinsey & Co., as a Business Analyst, where she worked on many projects, including Purchase & Supply Management, Growth Strategy and Information Technology Strategy of various corporates. She served with the slum rehabilitation proposal of McKinsey, which was part of its larger project for the future ...
247 Business ParkPhone: 91 22 3095 66666
Mumbai, Maharashtra 400083
Board Members Memberships*
General Manager of Strategic Marketing, Executive Director and Member of Corporate Social Responsibility Committee
Non-Executive Director and Chairman of Stakeholders Relationship Committee
Stanford Graduate School of Business
Stock Options*There is no Stock Options data available.
|Steven M. Klosk||Chief Executive Officer, President and Director|
|Samir Uttamlal Mehta M.B.A.||Executive Vice Chairman, Managing Director, Member of Securities Transfer & Stakeholders Relationship Committee and Member of Committee of Directors|
Torrent Pharmaceuticals Ltd.
|Hari Shankar Bhartia||Co-Chairman, Managing Director, Chairman of Corporate Governance Committee, Member of Compensation Committee, Member of Fund Raising Committee, Member of Finance Committee and Member of Sustainability & CSR Committee|
Jubilant Life Sciences Limited
|Arun Suresh Chandavarkar B.Tech., M.S., Ph.D.(Chemical Eng.)||Chief Executive Officer, Joint Managing Director and Additional Director|
|Murali Krishna Prasad Divi M. Pharm, Ph.D.||Chairman, Managing Director and Member of Corporate Social Responsibility Committee|
Divi's Laboratories Limited
|9.0M||Compensation as of Fiscal Year 2014.|